| Title : Genome sequencing of ovine isolates of Mycobacterium avium subspecies paratuberculosis offers insights into host association - Bannantine_2012_BMC.Genomics_13_89 |
| Author(s) : Bannantine JP , Wu CW , Hsu C , Zhou S , Schwartz DC , Bayles DO , Paustian ML , Alt DP , Sreevatsan S , Kapur V , Talaat AM |
| Ref : BMC Genomics , 13 :89 , 2012 |
| Abstract : |
| PubMedSearch : Bannantine_2012_BMC.Genomics_13_89 |
| PubMedID: 22409516 |
| Gene_locus related to this paper: mycav-DHMA , mycav-Q9KK87 , mycav-Q73T09 , mycpa-q73s39 , mycpa-q73s40 , mycpa-q73u73 , mycpa-q73ue0 , mycpa-q73xk5 , mycpa-q73yd6 , mycpa-q73ze1 , mycpa-q73zz5 , mycpa-q744k8 , mycpa-q745l1 |
| Title : Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study - Ballard_2008_Curr.Med.Res.Opin_24_2561 |
| Author(s) : Ballard C , Sauter M , Scheltens P , He Y , Barkhof F , van Straaten EC , van der Flier WM , Hsu C , Wu S , Lane R |
| Ref : Curr Med Res Opin , 24 :2561 , 2008 |
| Abstract : |
| PubMedSearch : Ballard_2008_Curr.Med.Res.Opin_24_2561 |
| PubMedID: 18674411 |
| Title : Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study - Poewe_2006_Mov.Disord_21_456 |
| Author(s) : Poewe W , Wolters E , Emre M , Onofrj M , Hsu C , Tekin S , Lane R |
| Ref : Movement Disorder , 21 :456 , 2006 |
| Abstract : |
| PubMedSearch : Poewe_2006_Mov.Disord_21_456 |
| PubMedID: 16229010 |
| Title : Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease - Burn_2006_Mov.Disord_21_1899 |
| Author(s) : Burn D , Emre M , McKeith I , De Deyn PP , Aarsland D , Hsu C , Lane R |
| Ref : Movement Disorder , 21 :1899 , 2006 |
| Abstract : |
| PubMedSearch : Burn_2006_Mov.Disord_21_1899 |
| PubMedID: 16960863 |
| Title : Serum paraoxonase (PON1) isozymes: the quantitative analysis of isozymes affecting individual sensitivity to environmental chemicals - La_2001_Drug.Metab.Dispos_29_566 |
| Author(s) : La Du BN , Billecke S , Hsu C , Haley RW , Broomfield CA |
| Ref : Drug Metabolism & Disposition: The Biological Fate of Chemicals , 29 :566 , 2001 |
| Abstract : |
| PubMedSearch : La_2001_Drug.Metab.Dispos_29_566 |
| PubMedID: 11259353 |
| Title : Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters - Billecke_2000_Drug.Metab.Dispos_28_1335 |
| Author(s) : Billecke S , Draganov D , Counsell R , Stetson P , Watson C , Hsu C , La Du BN |
| Ref : Drug Metabolism & Disposition: The Biological Fate of Chemicals , 28 :1335 , 2000 |
| Abstract : |
| PubMedSearch : Billecke_2000_Drug.Metab.Dispos_28_1335 |
| PubMedID: 11038162 |
| Title : Properties of the retained N-terminal hydrophobic leader sequence in human serum paraoxonase\/arylesterase - Sorenson_1999_Chem.Biol.Interact_119-120_243 |
| Author(s) : Sorenson RC , Aviram M , Bisgaier CL , Billecke S , Hsu C , La Du BN |
| Ref : Chemico-Biological Interactions , 119-120 :243 , 1999 |
| Abstract : |
| PubMedSearch : Sorenson_1999_Chem.Biol.Interact_119-120_243 |
| PubMedID: 10421458 |
| Title : Evidence that several conserved histidine residues are required for hydrolytic activity of human paraoxonase\/arylesterase - Doorn_1999_Chem.Biol.Interact_119-120_235 |
| Author(s) : Doorn JA , Sorenson RC , Billecke SS , Hsu C , La Du BN |
| Ref : Chemico-Biological Interactions , 119-120 :235 , 1999 |
| Abstract : |
| PubMedSearch : Doorn_1999_Chem.Biol.Interact_119-120_235 |
| PubMedID: 10421457 |
| Title : Human serum Paraoxonase\/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity - Sorenson_1999_Arterioscler.Thromb.Vasc.Biol_19_2214 |
| Author(s) : Sorenson RC , Bisgaier CL , Aviram M , Hsu C , Billecke S , La Du BN |
| Ref : Arterioscler Thromb Vasc Biol , 19 :2214 , 1999 |
| Abstract : |
| PubMedSearch : Sorenson_1999_Arterioscler.Thromb.Vasc.Biol_19_2214 |
| PubMedID: 10479665 |
| Title : Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase\/paraoxonase activities: selective action of human paraoxonase allozymes Q and R - Aviram_1998_Arterioscler.Thromb.Vasc.Biol_18_1617 |
| Author(s) : Aviram M , Billecke S , Sorenson R , Bisgaier C , Newton R , Rosenblat M , Erogul J , Hsu C , Dunlop C , La Du BN |
| Ref : Arterioscler Thromb Vasc Biol , 18 :1617 , 1998 |
| Abstract : |
| PubMedSearch : Aviram_1998_Arterioscler.Thromb.Vasc.Biol_18_1617 |
| PubMedID: 9763535 |